Page 5 - Joshuat Brumm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joshuat brumm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joshuat Brumm Today - Breaking & Trending Today

Dyne Therapeutics (NASDAQ:DYN) Stock Rating Lowered by StockNews.com

Dyne Therapeutics (NASDAQ:DYN) Stock Rating Lowered by StockNews.com
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom General , United Kingdom , Joshuat Brumm , Richard William Scalzo , Atlas Venture Life Science Advisors , Dyne Therapeutics Inc , Dyne Therapeutics Company Profile , Securities Exchange Commission , Franklin Resources Inc , Blackrock Inc , Dyne Therapeutics , Free Report , Get Free Report , Exchange Commission , Venture Life Science Advisors , Franklin Resources , Dyne Therapeutics Daily ,

Dyne Therapeutics (NASDAQ:DYN) Shares Down 7.9%

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) dropped 7.9% during trading on Friday . The stock traded as low as $10.82 and last traded at $10.82. Approximately 289,585 shares changed hands during mid-day trading, a decline of 29% from the average daily volume of 407,422 shares. The stock had previously closed at $11.75. Wall Street […] ....

United States , Richard William Scalzo , Joshuat Brumm , Raymond James , Atlas Venture Life Science Advisors , Securities Exchange Commission , Blackrock Inc , Franklin Resources Inc , Dyne Therapeutics Inc , Dyne Therapeutics , Get Rating , Exchange Commission , Venture Life Science Advisors , Franklin Resources , Dyne Therapeutics Daily ,

Dyne Therapeutics (NASDAQ:DYN) Trading Down 7.9%

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) dropped 7.9% during mid-day trading on Friday . The company traded as low as $10.82 and last traded at $10.82. Approximately 289,585 shares were traded during trading, a decline of 29% from the average daily volume of 407,422 shares. The stock had previously closed at $11.75. Analyst Upgrades […] ....

United States , Joshuat Brumm , Raymond James , Richard William Scalzo , Dyne Therapeutics Inc , Franklin Resources Inc , Blackrock Inc , Atlas Venture Life Science Advisors , Dyne Therapeutics Company Profile , Dyne Therapeutics , Get Rating , Chardan Capital , Therapeutics Trading Down , Venture Life Science Advisors , Franklin Resources , Dyne Therapeutics Daily ,

Dyne Therapeutics (NASDAQ:DYN) Raised to Hold at StockNews.com

StockNews.com upgraded shares of Dyne Therapeutics (NASDAQ:DYN – Get Rating) from a sell rating to a hold rating in a research note issued to investors on Friday. Other research analysts also recently issued research reports about the company. Chardan Capital raised their price objective on Dyne Therapeutics from $17.00 to $20.00 and gave the stock […] ....

United States , Raymond James , Joshuat Brumm , Securities Exchange Commission , Franklin Resources Inc , Atlas Venture Life Science Advisors , Dyne Therapeutics Inc , Blackrock Inc , Dyne Therapeutics , Get Rating , Exchange Commission , Venture Life Science Advisors , Franklin Resources , Dyne Therapeutics Daily ,

Dyne Therapeutics (NASDAQ:DYN) Lifted to Hold at StockNews.com

StockNews.com upgraded shares of Dyne Therapeutics (NASDAQ:DYN – Get Rating) from a sell rating to a hold rating in a report issued on Friday morning. Several other analysts have also commented on DYN. Raymond James raised shares of Dyne Therapeutics from an outperform rating to a strong-buy rating and increased their target price for the […] ....

United States , Joshuat Brumm , Richard William Scalzo , Raymond James , Group Plc , Tower Research Capital , Securities Exchange Commission , Allspring Global Investments Holdings , Dyne Therapeutics Company Profile , Sphera Funds Management , Dyne Therapeutics Inc , Dyne Therapeutics , Get Rating , Therapeutics Trading Down , Exchange Commission , Global Investments Holdings , Funds Management , General Group Plc , Research Capital , Dyne Therapeutics Daily ,